Registration Options

Webinar Date: 02/06/2019 12:00PM central
Activity Dates: 02/06/2019 - 06/30/2024

Session Summary

The Geriatric Psychopharmacology Community is proud to present Dr. Christopher Johnson. Dr. Johnson is a Clinical Professor of Sociology in America’s first MS in Dementia and Aging Studies program at Texas State University. HIs presentation describes the evolution of Kitwood’s social model of care movement in long term care. He addresses America’s stigmatizing and disempowering of persons living with dementia (PLWD). His view is that people with cognitive disabilities are living with, not dying from them. Full dementia citizenship involves identifying the strengths and biographical interests of PLWD. Clinicians and caregivers will be interested in hearing about the evolution of social care partnering. Advocacy for dementia citizenship results in the development of our “dementia studies” program at Texas State University--an institution with a history of promoting human rights starting with its famous alum President Lyndon Baines Johnson.

Drugs are a last resort in addressing challenging behaviors of PLWD. Dr. Johnson’s presentation shows how PLWD can transcend loneliness and boredom by social rather than medical interventions. De-medicalizing dementia care by social engagement involves finding meaningful work, hobbies and interests that connect to PLWD biographies as they time travel. In 2016, Texas AARP addressed Texas ranking 48th in the nation in the prevalence of antipsychotics in nursing homes. The report shows that roughly 20% of nursing home residents are being inappropriately given these drugs. Dr. Johnson addresses de-medicalizing dementia care and cutting polypharmacy by connecting PLWD with meaningful activities and experiences. Tjia and associates’ 2012 research found little benefit from such drugs for behavioral management of PLWD. Growing evidence for excessive morbidity and mortality for these often unneeded medications is appearing in the geriatric literature. Sadly, there is a continual use of expensive atypical anti-psychotics despite FDA regulations and warnings which call for a reduction in anti-psychotic use. 

Psychiatric Pharmacists caring for patients with dementia are encouraged to attend this engaging and thought provoking presentation.

Continuing Education Credit and Disclosures

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.